Woods said he was looking to "play more" in 2025 and speculation is that he wants to play twice before the Masters. PALM BEACH GARDENS — Tiger Woods gave no hint as to when he will return to the ...

Diversified healthcare company Solventum (NYSE:SOLV) reported fourth-quarter 2024 earnings on Thursday, Feb. 27, that topped analysts' consensus estimates. Adjusted EPS for the quarter came in at ...

Stifel Nicolaus analyst Rick Wise maintained a Buy rating on Solventum Corporation (SOLV – Research Report) today and set a price target of $88.00. The company’s shares closed yesterday at $83.44.

My name is Ellie, and I will be your conference call operator today. I would like to welcome everyone to Solventum's fourth quarter 2024 earnings call. (Operator Instructions) Thank you. I would now ...

Analysts fell to the sidelines weighing in on Morgan Stanley Direct Lending Fund (MSDL – Research Report) and Solventum Corporation (SOLV – Research Report) with neutral ratings, indicating ...

Finally, Morgan Stanley lifted their price target on shares of Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research note on Monday, November 11th.

ST. PAUL, Minn. - Solventum Corporation (NYSE:SOLV) reported fourth-quarter earnings that fell short of analyst expectations, sending shares down 2% in after-hours trading. The healthcare technology ...

*Data in the schedule above is intentionally rounded to the nearest million and, therefore, may not sum. (a) Consists of severance associated with restructuring programs. (b) Consists ...

Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 1.9% year on year to $2.07 billion. Its non-GAAP profit of $1 ...

Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 1.9% year on year to $2.07 billion. Its non-GAAP profit of $1.41 ...